In the BioHarmony Drug Report Database
Mepenzolate
Cantil (mepenzolate) is a small molecule pharmaceutical. Mepenzolate was first approved as Cantil on 1982-01-01. It is used to treat peptic ulcer in the USA. It is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M3, and muscarinic acetylcholine receptor M4.
Trade Name
|
Cantil |
|---|---|
Common Name
|
mepenzolate |
ChEMBL ID
|
CHEMBL524004 |
Indication
|
peptic ulcer |
Drug Class
|
Image (chem structure or protein)